We are live on
!
Find out more
WCM Investment Management Portfolio holdings
AUM
$43.8B
1-Year Est. Return
42.28%
This Fund
S&P 500
This Quarter
Est. Return
+46.85%
1 Year Est. Return
+42.28%
3 Year Est. Return
+149.38%
5 Year Est. Return
+174.91%
10 Year Est. Return
+944.06%
AUM
$26.1B
AUM Growth
+$7.95B
(+44%)
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
4.05%
Top 10 Holdings %
Top 10 Hldgs %
69.35%
Holding
195
New
15
Increased
130
Reduced
16
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
lululemon athletica
LULU
|
+$311M |
| 2 |
Steris
STE
|
+$186M |
| 3 |
Mercado Libre
MELI
|
+$154M |
| 4 |
ServiceNow
NOW
|
+$133M |
| 5 |
TSMC
TSM
|
+$117M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$955M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$10.9M |
| 3 |
Shopify
SHOP
|
+$6.7M |
| 4 |
Brink's
BCO
|
+$6.32M |
| 5 |
EXAS
Exact Sciences
EXAS
|
+$5.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.45% |
| 2 | Healthcare | 25.02% |
| 3 | Consumer Discretionary | 19.68% |
| 4 | Industrials | 9.19% |
| 5 | Financials | 6.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCF
126
DELISTED
Chase Corporation
CCF
| $5.31M | 0.02% |
51,813
+3,346
| +7% | +$313K |
|
127
AMN Healthcare
AMN
$1.42B
| $5.13M | 0.02% |
113,462
+53,371
| +89% | +$2.55M |
|
128
Surgery Partners
SGRY
$2.09B
| $5.11M | 0.02% |
+441,970
| New | +$4.84M |
|
|
TRHC
129
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $5.1M | 0.02% |
93,220
-31,079
| -25% | -$1.78M |
|
130
Ultragenyx Pharmaceutical
RARE
$2.64B
| $4.98M | 0.02% |
63,646
+2,075
| +3% | +$137K |
|
|
BHVN
131
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.51M | 0.02% |
61,750
+2,235
| +4% | +$119K |
|
132
Regis Corp
RGS
$70.8M
| $4.39M | 0.02% |
26,810
+3,193
| +14% | +$599K |
|
133
Mine Safety
MSA
$7.45B
| $4.34M | 0.02% |
37,909
+1,255
| +3% | +$140K |
|
134
Iovance Biotherapeutics
IOVA
$2.9B
| $4.33M | 0.02% |
157,822
-36,316
| -19% | -$1.19M |
|
135
Glaukos
GKOS
$10.7B
| $4.27M | 0.02% |
+111,061
| New | +$4.14M |
|
136
Ligand Pharmaceuticals
LGND
$6.42B
| $4.07M | 0.02% |
58,322
+4,740
| +9% | +$300K |
|
137
Fate Therapeutics
FATE
$322M
| $4.04M | 0.02% |
117,727
+4,253
| +4% | +$127K |
|
138
Insmed
INSM
$29.4B
| $4.03M | 0.02% |
146,271
+45,211
| +45% | +$1.07M |
|
|
RETA
139
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $3.85M | 0.01% |
24,655
+12,773
| +107% | +$1.94M |
|
|
NP
140
DELISTED
Neenah, Inc. Common Stock
NP
| $3.84M | 0.01% |
77,678
+5,871
| +8% | +$282K |
|
141
Axsome Therapeutics
AXSM
$11.4B
| $3.79M | 0.01% |
46,005
+10,484
| +30% | +$807K |
|
|
MYOK
142
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $3.46M | 0.01% |
+35,760
| New | +$2.98M |
|
143
Acadia Pharmaceuticals
ACAD
$5.06B
| $3.38M | 0.01% |
69,770
-27,891
| -29% | -$1.34M |
|
144
Synopsys
SNPS
$78.8B
| $3.36M | 0.01% |
17,230
+8,769
| +104% | +$1.45M |
|
145
BridgeBio Pharma
BBIO
$16.6B
| $3.24M | 0.01% |
99,273
+33,050
| +50% | +$1.01M |
|
146
Amazon
AMZN
$3T
| $2.93M | 0.01% |
21,240
| – | – |
|
147
Netflix
NFLX
$318B
| $2.73M | 0.01% |
60,000
-112,910
| -65% | -$4.81M |
|
148
Simulations Plus
SLP
$371M
| $2.52M | 0.01% |
42,218
-1,155
| -3% | -$50.8K |
|
149
Coherus Oncology
CHRS
$192M
| $2.25M | 0.01% |
126,176
+4,622
| +4% | +$78.2K |
|
|
TPTX
150
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.14M | 0.01% |
+33,072
| New | +$1.91M |
|
Similar funds
LP
WCM Investment Management's Q2 2020 Portfolio in Review
As of Q2 2020, WCM Investment Management held 195 positions worth $26.1B, up 44% from $18.1B the previous quarter. Its ten largest holdings account for 69% of the portfolio.
WCM Investment Management deployed $1.06B of net new capital in Q2 2020, opening 15 new positions and adding to 130 existing holdings. Its largest new stake was ServiceNow: 1,886,120 shares worth $153M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $10.9M trimmed.
- WCM Investment Management's largest Q2 2020 buy was ServiceNow: 1,886,120 shares worth $153M.
- WCM Investment Management added most to lululemon athletica in Q2 2020, an estimated $311M increase.
- WCM Investment Management's biggest Q2 2020 reduction was iShares MSCI EAFE ETF, cutting an estimated $10.9M.
- WCM Investment Management fully exited Chubb in Q2 2020, selling an estimated $955M.
- WCM Investment Management's ten largest holdings make up 69% of its $26.1B portfolio in Q2 2020.
- WCM Investment Management opened 15 new positions and closed 15 in Q2 2020.
- WCM Investment Management's portfolio value rose 44% quarter-over-quarter to $26.1B.
Based on WCM Investment Management's 13F filing for Q2 2020, filed 18 Aug 2020.